ANTI-LY6G

ANTI-LY6G has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 14, 2026: “Immune-cell traps induce senescence-related changes in eye cells”.

Intervention

1 paper studies it1 findingUpdated Nov 14, 2026

1 new paper in 30 daysSee all 1 papers on ANTI-LY6G

At a glance

The findings reach mice, none yet in people. 1 lab.

1 lab

Animals1

What did studies of ANTI-LY6G find?

Studies of ANTI-LY6G measured one outcome, retinal function.

Retinal function

upin mice1

1 study

ANTI-LY6G improves retinal function in mice (sodium iodate-treated mice).
“Suppression of NET formation with GSK484, as well as neutrophil depletion with anti-Ly6G, reduced retinal damage, preserved RPE morphology, and improved retinal function.”
Animalssodium iodate-treated miceretina
Immune-cell traps induce senescence-related changes in eye cells
International immunopharmacologyNov 14, 2026

Latest

1 paper in 12 months

International ImmunopharmacologyNov 14

Immune-cell traps induce senescence-related changes in eye cells

Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.

Human cell studyCellular senescence

Paper